Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)

Laurel B. Darragh; Michael M. Knitz; Junxiao Hu; Eric T. Clambey; Jennifer Backus; Andrew Dumit; Von Samedi; Andrew Bubak; Casey Greene; Timothy Waxweiler; Sanjana Mehrotra; Shilpa Bhatia; Jacob Gadwa; Thomas Bickett; Miles Piper; Kareem Fakhoury; Arthur Liu; Joshua Petit; Daniel Bowles; Ashesh Thaker; Kimberly Atiyeh; Julie Goddard; Robert Hoyer; Adrie Van Bokhoven; Kimberly Jordan; Antonio Jimeno; Angelo D’Alessandro; David Raben; Jessica D. McDermott; Sana D. Karam

doi:10.1038/s43018-024-00724-1

Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)

Laurel B. Darragh, Michael M. Knitz, Junxiao Hu, Eric T. Clambey, Jennifer Backus, Andrew Dumit, Von Samedi, Andrew Bubak, Casey Greene, Timothy Waxweiler, Sanjana Mehrotra, Shilpa Bhatia, Jacob Gadwa, Thomas Bickett, Miles Piper, Kareem Fakhoury, Arthur Liu, Joshua Petit, Daniel Bowles, Ashesh ThakerKimberly Atiyeh, Julie Goddard, Robert Hoyer, Adrie Van Bokhoven, Kimberly Jordan, Antonio Jimeno, Angelo D’Alessandro, David Raben, Jessica D. McDermott, Sana D. Karam

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Correction to: Nature Cancer, published online 25 November 2022. In the version of the article initially published, the clinical trial protocol was missing and has now been added as Supplementary Information.

Original language	English
Pages (from-to)	210
Number of pages	1
Journal	Nature Cancer
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/s43018-024-00724-1
State	Published - Jan 2024

Access to Document

10.1038/s43018-024-00724-1

Fingerprint

Dive into the research topics of 'Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)'. Together they form a unique fingerprint.

Cite this

Darragh, L. B., Knitz, M. M., Hu, J., Clambey, E. T., Backus, J., Dumit, A., Samedi, V., Bubak, A., Greene, C., Waxweiler, T., Mehrotra, S., Bhatia, S., Gadwa, J., Bickett, T., Piper, M., Fakhoury, K., Liu, A., Petit, J., Bowles, D., ... Karam, S. D. (2024). Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6). Nature Cancer, 5(1), 210. https://doi.org/10.1038/s43018-024-00724-1

@article{4f87b79106134b4eaac8e1c4d7a294e0,

title = "Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)",

abstract = "Correction to: Nature Cancer, published online 25 November 2022. In the version of the article initially published, the clinical trial protocol was missing and has now been added as Supplementary Information.",

author = "Darragh, {Laurel B.} and Knitz, {Michael M.} and Junxiao Hu and Clambey, {Eric T.} and Jennifer Backus and Andrew Dumit and Von Samedi and Andrew Bubak and Casey Greene and Timothy Waxweiler and Sanjana Mehrotra and Shilpa Bhatia and Jacob Gadwa and Thomas Bickett and Miles Piper and Kareem Fakhoury and Arthur Liu and Joshua Petit and Daniel Bowles and Ashesh Thaker and Kimberly Atiyeh and Julie Goddard and Robert Hoyer and {Van Bokhoven}, Adrie and Kimberly Jordan and Antonio Jimeno and Angelo D{\textquoteright}Alessandro and David Raben and McDermott, {Jessica D.} and Karam, {Sana D.}",

note = "Publisher Copyright: {\textcopyright} 2024, The Author(s).",

year = "2024",

month = jan,

doi = "10.1038/s43018-024-00724-1",

language = "English",

volume = "5",

pages = "210",

journal = "Nature Cancer",

issn = "2662-1347",

number = "1",

}

Darragh, LB, Knitz, MM, Hu, J, Clambey, ET, Backus, J, Dumit, A, Samedi, V, Bubak, A, Greene, C, Waxweiler, T, Mehrotra, S, Bhatia, S, Gadwa, J, Bickett, T, Piper, M, Fakhoury, K, Liu, A, Petit, J, Bowles, D, Thaker, A, Atiyeh, K, Goddard, J, Hoyer, R, Van Bokhoven, A, Jordan, K, Jimeno, A, D’Alessandro, A, Raben, D, McDermott, JD & Karam, SD 2024, 'Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)', Nature Cancer, vol. 5, no. 1, pp. 210. https://doi.org/10.1038/s43018-024-00724-1

Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6). / Darragh, Laurel B.; Knitz, Michael M.; Hu, Junxiao et al.
In: Nature Cancer, Vol. 5, No. 1, 01.2024, p. 210.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Publisher Correction

T2 - A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)

AU - Darragh, Laurel B.

AU - Knitz, Michael M.

AU - Hu, Junxiao

AU - Clambey, Eric T.

AU - Backus, Jennifer

AU - Dumit, Andrew

AU - Samedi, Von

AU - Bubak, Andrew

AU - Greene, Casey

AU - Waxweiler, Timothy

AU - Mehrotra, Sanjana

AU - Bhatia, Shilpa

AU - Gadwa, Jacob

AU - Bickett, Thomas

AU - Piper, Miles

AU - Fakhoury, Kareem

AU - Liu, Arthur

AU - Petit, Joshua

AU - Bowles, Daniel

AU - Thaker, Ashesh

AU - Atiyeh, Kimberly

AU - Goddard, Julie

AU - Hoyer, Robert

AU - Van Bokhoven, Adrie

AU - Jordan, Kimberly

AU - Jimeno, Antonio

AU - D’Alessandro, Angelo

AU - Raben, David

AU - McDermott, Jessica D.

AU - Karam, Sana D.

PY - 2024/1

Y1 - 2024/1

N2 - Correction to: Nature Cancer, published online 25 November 2022. In the version of the article initially published, the clinical trial protocol was missing and has now been added as Supplementary Information.

AB - Correction to: Nature Cancer, published online 25 November 2022. In the version of the article initially published, the clinical trial protocol was missing and has now been added as Supplementary Information.

UR - http://www.scopus.com/inward/record.url?scp=85181919497&partnerID=8YFLogxK

U2 - 10.1038/s43018-024-00724-1

DO - 10.1038/s43018-024-00724-1

M3 - Comment/debate

C2 - 38200246

AN - SCOPUS:85181919497

SN - 2662-1347

VL - 5

SP - 210

JO - Nature Cancer

JF - Nature Cancer

IS - 1

ER -

Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC (Nature Cancer, (2022), 3, 11, (1300-1317), 10.1038/s43018-022-00450-6)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this